Sana Biotechnology (SANA) Goodwill & Intangibles (2020 - 2026)
Sana Biotechnology recorded quarterly Goodwill & Intangibles of $199.8 million in Q1 2026, little changed quarter-over-quarter from $199.8 million in Q4 2025, and little changed year-over-year from $199.8 million in Q1 2025.
Sana Biotechnology's Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $199.8 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $199.8 million; the TTM figure through Mar 2026 stood at $199.8 million (changed 0.0% YoY), while the FY2025 annual figure was $199.8 million, changed 0.0% from the prior year.
- Goodwill & Intangibles came in at $199.8 million for Q1 2026 at Sana Biotechnology, roughly flat from $199.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $199.8 million in Q1 2022 to a low of $199.8 million in Q1 2022.
- A 5-year average of $199.8 million and a median of $199.8 million in 2022 frame the typical range for Goodwill & Intangibles.
- On a YoY basis, Goodwill & Intangibles climbed as much as 0.01% in 2022 and fell as far as 0.0% in 2022.
- Sana Biotechnology's Goodwill & Intangibles stood at $199.8 million in 2022, then changed by 0.0% to $199.8 million in 2023, then changed by 0.0% to $199.8 million in 2024, then changed by 0.0% to $199.8 million in 2025, then changed by 0.0% to $199.8 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $199.8 million, $199.8 million, and $199.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199.82 Mn |
| Dec 31, 2025 | 199.82 Mn |
| Sep 30, 2025 | 199.82 Mn |
| Jun 30, 2025 | 199.82 Mn |
| Mar 31, 2025 | 199.82 Mn |
| Dec 31, 2024 | 199.82 Mn |
| Sep 30, 2024 | 199.82 Mn |
| Jun 30, 2024 | 199.82 Mn |
| Mar 31, 2024 | 199.82 Mn |
| Dec 31, 2023 | 199.82 Mn |
| Sep 30, 2023 | 199.82 Mn |
| Jun 30, 2023 | 199.82 Mn |
| Mar 31, 2023 | 199.82 Mn |
| Dec 31, 2022 | 199.82 Mn |
| Sep 30, 2022 | 199.82 Mn |
| Jun 30, 2022 | 199.82 Mn |
| Mar 31, 2022 | 199.82 Mn |
| Dec 31, 2021 | 199.82 Mn |
| Sep 30, 2021 | 199.80 Mn |
| Jun 30, 2021 | 199.83 Mn |
| Mar 31, 2021 | 199.83 Mn |
| Dec 31, 2020 | 199.82 Mn |